Literature DB >> 28316014

Rescue of recombinant Newcastle disease virus: a short history of how it all started.

Aidin Molouki1, Ben Peeters2.   

Abstract

Reverse genetics of viruses has come a long way, and many recombinant viruses have been generated since the first successful "rescues" were reported in the late 1970s. Recombinant Newcastle disease virus (rNDV), a non-segmented negative-sense RNA virus (NSNSV), was first rescued in 1999 using a reverse genetics approach similar to that reported for other recombinant viruses of the order Mononegavirales a few years before. The route from an original NDV isolate to the generation of its recombinant counterpart requires many steps that have to be sequentially and carefully completed. Background knowledge of each of these steps is essential because it allows one to make the best choices for fulfilling the specific requirements of the final recombinant virus. We have previously reviewed the latest strategies in cloning the NDV full-length cDNA into transcription vectors and the use of different RNA polymerase systems for the generation of viral RNA from plasmid DNA. In this article, we review a number of discoveries on the mechanism of transcription and replication of NDV, including a brief history behind the discovery of its RNP complex. This includes the generation of artificial and functional RNP constructs, in combination with the smart use of available knowledge and technologies that ultimately resulted in rescue of the first rNDV.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28316014     DOI: 10.1007/s00705-017-3308-2

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  6 in total

1.  Design and Production of Newcastle Disease Virus for Intratumoral Immunomodulation.

Authors:  Gayathri Vijayakumar; Dmitriy Zamarin
Journal:  Methods Mol Biol       Date:  2020

Review 2.  Development of Molecular Mechanisms and Their Application on Oncolytic Newcastle Disease Virus in Cancer Therapy.

Authors:  Fang Huang; Chuanjing Dai; Youni Zhang; Yuqi Zhao; Yigang Wang; Guoqing Ru
Journal:  Front Mol Biosci       Date:  2022-07-04

3.  Effects of the HN Antigenic Difference between the Vaccine Strain and the Challenge Strain of Newcastle Disease Virus on Virus Shedding and Transmission.

Authors:  Jingjing Liu; Jie Zhu; Haixu Xu; Juan Li; Zenglei Hu; Shunlin Hu; Xiaoquan Wang And; Xiufan Liu
Journal:  Viruses       Date:  2017-08-15       Impact factor: 5.048

Review 4.  Immunobiology of Newcastle Disease Virus and Its Use for Prophylactic Vaccination in Poultry and as Adjuvant for Therapeutic Vaccination in Cancer Patients.

Authors:  Volker Schirrmacher
Journal:  Int J Mol Sci       Date:  2017-05-20       Impact factor: 5.923

5.  Rapid Generation of a Recombinant Genotype VIII Newcastle Disease Virus (NDV) Using Full-Length Synthetic cDNA.

Authors:  Kavitha Murulitharan; Khatijah Yusoff; Abdul Rahman Omar; Ben P H Peeters; Aidin Molouki
Journal:  Curr Microbiol       Date:  2021-03-04       Impact factor: 2.188

Review 6.  The Development of Classical Swine Fever Marker Vaccines in Recent Years.

Authors:  Fangfang Li; Bingke Li; Xinni Niu; Wenxian Chen; Yuwan Li; Keke Wu; Xiaowen Li; Hongxing Ding; Mingqiu Zhao; Jinding Chen; Lin Yi
Journal:  Vaccines (Basel)       Date:  2022-04-13
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.